Back to Results

CVS Health Corp (CVS)

Featured in High-Momentum Stocks

CVS Health Corp is a U.S. healthcare company listed on the NYSE under the ticker CVS. The company operates through three segments: Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness. Its Health Care Benefits business provides a range of health insurance products and related services, including medical, pharmacy, dental, and behavioral health coverage, along with Medicare Advantage, Medicare Supplement, and Medicaid-related management services. The Health Services segment focuses on pharmacy benefit management and related administrative and clinical services. Its Pharmacy & Consumer Wellness segment sells prescription drugs, over-the-counter medicines, and consumer health and personal care products, while also supporting pharmacy distribution and services for care facilities. Founded in 1963 and headquartered in Woonsocket, Rhode Island, the company was formerly known as CVS Caremark Corporation before adopting its current name in 2014.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-CVS
$136.16
25.0% Upside
Undervalued
$111.92
2.8% Upside
Fair
Good
July 23, 2026
August 3, 2026
2.66
2.5%
August 5, 2026
47.4x
1.8x
0.3x
137.3 B
173.2 B
36.3%
99.8%
4.1
116.1%
252.2%
Send a message
Valuation • Fair Value

CVS Health Corp (NYSE-CVS) Fair Value by Valuation Model

Compare the primary fair value estimate for CVS Health Corp (NYSE-CVS) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$136.16

Estimated upside of 25.0% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$162.25

Discounted cash flow valuation reference.

Ben Graham Formula Value

$25.50

Classic Ben Graham valuation formula reference.

DDM Fair Value

$136.55

Dividend discount model valuation reference.

EPV Fair Value

$152.19

Earnings power value estimate.

Comps Fair Value

$107.26

Comparable-company valuation reference.

Analyst Price Target

$111.92

Analysts imply upside of 2.8%.

How to read these valuation models

Use this section to compare the primary fair value estimate for CVS Health Corp (NYSE-CVS) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for CVS Health Corp (NYSE-CVS)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

405.6 B

Current operating scale indicator.

Revenue Forecast

408.3 B

Forward revenue estimate.

EBITDA

15.412 B

Current operating profitability reference.

EBITDA Forecast

18.503 B

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review CVS Health Corp (NYSE-CVS) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for CVS Health Corp (NYSE-CVS)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Good

Positive financial-health read.

Piotroski Score

6

Mid-range quality score.

Beneish M-Score

-2.42

No elevated caution signal from this screen.

Altman Z-Score

4.1

Relatively strong balance-sheet zone.

FCF / Net Income

252.2%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for CVS Health Corp (NYSE-CVS). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for CVS Health Corp (NYSE-CVS)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 5, 2026

Days to Earnings

15

Dividend Payment Date

August 3, 2026

Ex-Dividend Date

July 23, 2026

Dividend Yield

2.5%

Income yield reference.

Upcoming Dividend

2.66

Upcoming distribution amount.

Payment Type

Cash

Distribution type as reported in the data.

Dividend Currency

USD

Currency used for the distribution.

Payout Ratio

116.1%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for CVS Health Corp (NYSE-CVS), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

CVS Health Corp (NYSE-CVS) Stock Forecast & Technical Outlook

Review CVS Health Corp (NYSE-CVS) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Buy

The 15-minute technical read for CVS Health Corp (NYSE-CVS) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Buy

The 1-hour technical read for CVS Health Corp (NYSE-CVS) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Buy

The daily technical read for CVS Health Corp (NYSE-CVS) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Buy

The weekly technical read for CVS Health Corp (NYSE-CVS) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Buy

The monthly technical read for CVS Health Corp (NYSE-CVS) is currently Strong Buy. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for CVS Health Corp (NYSE-CVS)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, CVS Health Corp (NYSE-CVS) has a Strong Buy consensus, with 18 buy, 4 hold and 0 sell recommendations in the current data set.

Buy 18
Hold 4
Sell 0
FAQ • Fast Investor Answers

CVS Health Corp (NYSE-CVS) Stock FAQ

Quick answers about CVS Health Corp (NYSE-CVS) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$136.16
Estimated upside 25.0%
Valuation Rating
Undervalued
Estimated upside of 25.0%
Analyst Target
$111.92
Implied upside 2.8%
Financial Health
Good
Current financial-health read

The current fair value estimate for CVS Health Corp (NYSE-CVS) is $136.16. This implies an estimated upside of 25.0% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 25.0% versus the current market price.

The available analyst price target for CVS Health Corp (NYSE-CVS) is $111.92. The analyst target implies estimated upside of 2.8%.

The current financial health read for CVS Health Corp (NYSE-CVS) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for CVS Health Corp (NYSE-CVS) is August 5, 2026.

Based on the current data, dividend yield is 2.5%, upcoming dividend amount is 2.66, ex-dividend date is July 23, 2026, payment date is August 3, 2026.

The current P/E ratio listed for CVS Health Corp (NYSE-CVS) is 47.4x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for CVS Health Corp is 137.3 B.

The current enterprise value listed for CVS Health Corp is 173.2 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for CVS Health Corp is NYSE-CVS, and the stock is listed on NYSE.

CVS Health Corp (NYSE-CVS) is listed on NYSE.

The current debt-to-total-capital ratio listed for CVS Health Corp is 36.3%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for CVS Health Corp is 99.8%. Free float helps investors understand how much of the share base is available for public trading.

Similar Healthcare Providers & Services Stocks on NYSE View more

Unitedhealth Group (UNH) Unitedhealth Group (UNH)
McKesson Corporation (MCK) McKesson Corporation (MCK)
Elevance Health Inc (ELV) Elevance Health Inc (ELV)
HCA Holdings Inc (HCA) HCA Holdings Inc (HCA)
Cigna Corp (CI) Cigna Corp (CI)
Cencora Inc (COR) Cencora Inc (COR)
Cardinal Health Inc (CAH) Cardinal Health Inc (CAH)
Humana Inc (HUM) Humana Inc (HUM)
Centene Corp (CNC) Centene Corp (CNC)
Labcorp Holdings Inc (LH) Labcorp Holdings Inc (LH)
Quest Diagnostics Incorporated (DGX) Quest Diagnostics Incorporated (DGX)
Tenet Healthcare Corporation (THC) Tenet Healthcare Corporation (THC)
DaVita HealthCare Partners Inc (DVA) DaVita HealthCare Partners Inc (DVA)
Fresenius Medical Care Corporation (FMS) Fresenius Medical Care Corporation (FMS)
Molina Healthcare Inc (MOH) Molina Healthcare Inc (MOH)
Encompass Health Corp (EHC) Encompass Health Corp (EHC)
Universal Health Services Inc (UHS) Universal Health Services Inc (UHS)
Hims Hers Health Inc (HIMS) Hims Hers Health Inc (HIMS)
PACS Group Inc (PACS) PACS Group Inc (PACS)
Chemed Corp (CHE) Chemed Corp (CHE)
Hinge Health Inc (HNGE) Hinge Health Inc (HNGE)
Concentra Group Holdings Parent Inc (CON) Concentra Group Holdings Parent Inc (CON)
Brookdale Senior Living Inc (BKD) Brookdale Senior Living Inc (BKD)
National HealthCare Corporation (NHC) National HealthCare Corporation (NHC)